Latest Period
Q2 2026
Security Snapshot
Roivant Sciences Ltd. - Common Shares (ROIV) Institutional Ownership
CUSIP: G76279101
13F Institutional Holders and Ownership History from Q4 2021 to Q2 2026
Institutions Reporting
495
Shares (Excl. Options)
555,495,880
Price
$35.39
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares
- Symbol
- ROIV on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 555,495,880
- Total 13F value
- $19,660,782,995
- Portfolio coverage rank
- 0.03%
- Share change
- +27,341,623
- Value change
- +$1,005,619,693
- Number of holders
- 495
- Shares outstanding
- 713,919,053
- SEC-reported price per share
- $35.39
- Insider filing price
- $35.39
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ROIV - Roivant Sciences Ltd. - Common Shares is tracked under CUSIP G76279101.
- 495 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 443 to 495 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $14,668,498,624 to $19,660,782,995.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 495 institutions filings for Q2 2026.
Security key
G76279101
Latest holder period
Q2 2026
13F holders
495
13D/G owners
6
CIK / CUSIP context first
Open Q2 2026 holders
ROIV full holder history
Roivant Sciences Ltd. SEC filings
Roivant Sciences Ltd. company facts
Roivant Sciences Ltd. insider transactions
Roivant Sciences Ltd. 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G76279101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
ROIV
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 10% | +8% | $1,691,539,587 | +$180,585,293 | 73,641,253 | +12% | FMR LLC | 27 Feb 2026 |
| MORGAN STANLEY | 5.7% | -17% | $1,440,138,931 | -$310,740,090 | 40,693,386 | -18% | Morgan Stanley | 30 Jun 2026 |
| QVT Financial LP | 4.3% | -55% | $319,084,556 | -$395,435,884 | 29,381,635 | -55% | QVT Financial LP | 30 Jun 2025 |
| Ramaswamy Vivek | 3.6% | -46% | $723,405,700 | -$648,581,977 | 25,534,970 | -47% | Ramaswamy Vivek | 31 Mar 2026 |
| VIKING GLOBAL INVESTORS LP | 3.4% | -32% | $356,989,793 | -$161,027,803 | 23,594,831 | -31% | VIKING GLOBAL INVESTORS LP | 30 Sep 2025 |
| SB INVESTMENT ADVISERS (UK) LTD | 2.3% | -58% | $357,488,273 | -$520,575,193 | 16,413,603 | -59% | SB Investment Advisers (UK) Limited | 31 Dec 2025 |
As of 30 Jun 2026, 495 institutional investors reported holding 555,495,880 shares of Roivant Sciences Ltd. - Common Shares (ROIV). This represents 78% of the company’s total 713,919,053 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
58%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 11% | 81,020,390 | +3.9% | 0.12% | $2,867,311,587 |
| BlackRock, Inc. | 6.8% | 48,236,091 | +9% | 0.03% | $1,707,075,250 |
| MORGAN STANLEY | 6% | 42,592,905 | -18% | 0.08% | $1,507,362,964 |
| QVT Financial LP | 3.3% | 23,723,074 | -5.7% | 54% | $839,559,589 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.1% | 22,123,198 | +7% | 0.02% | $782,939,977 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3% | 21,641,339 | +9.1% | 0.03% | $765,886,987 |
| GOLDMAN SACHS GROUP INC | 2.6% | 18,556,458 | +67% | 0.07% | $656,713,035 |
| STATE STREET CORP | 2.5% | 17,795,975 | +9.9% | 0.02% | $629,799,555 |
| UBS Group AG | 2.4% | 17,466,641 | -23% | 0.1% | $618,144,425 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 2% | 14,309,000 | +48% | 3% | $506,395,510 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 11,674,380 | +15% | 0.02% | $425,535,991 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.4% | 10,349,328 | -19% | 0.51% | $366,262,718 |
| Two Seas Capital LP | 1.2% | 8,475,356 | -9.1% | 11% | $299,942,849 |
| Assenagon Asset Management S.A. | 1.2% | 8,362,952 | +18% | 0.38% | $295,964,871 |
| PERCEPTIVE ADVISORS LLC | 1.1% | 8,085,461 | -2.4% | 4.4% | $286,144,465 |
| Patient Square Capital LP | 1.1% | 8,020,928 | -1.8% | 44% | $283,860,642 |
| Invesco Ltd. | 1.1% | 7,531,192 | +17% | 0.02% | $266,528,885 |
| Darwin Global Management, Ltd. | 0.95% | 6,747,300 | -0.74% | 6.2% | $234,333,729 |
| AQR CAPITAL MANAGEMENT LLC | 0.93% | 6,633,560 | +12% | 0.08% | $234,031,996 |
| VIKING GLOBAL INVESTORS LP | 0.88% | 6,271,467 | -5.7% | 0.63% | $221,947,217 |
| Rubric Capital Management LP | 0.84% | 6,000,000 | +20% | 1.9% | $212,340,000 |
| CITADEL ADVISORS LLC | 0.78% | 5,576,261 | +122% | 0.11% | $197,343,877 |
| DIMENSIONAL FUND ADVISORS LP | 0.73% | 5,230,417 | -30% | 0.03% | $185,062,802 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.67% | 4,816,741 | -31% | 0.02% | $170,465,000 |
| NORGES BANK | 0.66% | 4,747,472 | 0.02% | $168,013,034 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
19
Latest
Q2 2026
Rows shown
1-19 of 19
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 555,495,880 | $19,660,782,995 | +$1,005,619,693 | $35.39 | 495 |
| 2026 Q1 | 530,208,313 | $14,668,498,624 | +$592,557,742 | $27.70 | 443 |
| 2025 Q4 | 508,798,279 | $11,037,472,271 | +$194,822,522 | $21.70 | 396 |
| 2025 Q3 | 501,599,656 | $7,589,044,056 | -$160,221,313 | $15.13 | 336 |
| 2025 Q2 | 514,772,354 | $5,801,411,223 | -$418,510,172 | $11.27 | 337 |
| 2025 Q1 | 553,328,719 | $5,583,781,669 | -$111,475,682 | $10.09 | 310 |
| 2024 Q4 | 562,446,665 | $6,653,171,538 | -$86,396,710 | $11.83 | 312 |
| 2024 Q3 | 569,136,749 | $6,567,461,922 | +$223,573,966 | $11.54 | 291 |
| 2024 Q2 | 546,001,457 | $5,771,073,920 | +$151,629,366 | $10.57 | 293 |
| 2024 Q1 | 531,561,894 | $5,603,149,203 | -$165,817,358 | $10.54 | 258 |
| 2023 Q4 | 541,631,584 | $6,081,436,620 | -$171,734,221 | $11.23 | 223 |
| 2023 Q3 | 545,872,779 | $6,375,349,918 | +$537,705,852 | $11.68 | 205 |
| 2023 Q2 | 497,346,775 | $5,012,967,398 | +$397,737,203 | $10.08 | 178 |
| 2023 Q1 | 459,356,125 | $3,389,932,964 | +$349,480,110 | $7.38 | 144 |
| 2022 Q4 | 411,727,361 | $3,289,525,255 | +$291,883,961 | $7.99 | 107 |
| 2022 Q3 | 370,512,297 | $1,192,938,093 | +$30,768,202 | $3.22 | 75 |
| 2022 Q2 | 360,483,554 | $1,467,028,314 | +$45,607,814 | $4.07 | 71 |
| 2022 Q1 | 349,161,599 | $1,724,680,470 | +$48,168,384 | $4.94 | 50 |
| 2021 Q4 | 339,213,133 | $3,416,732,000 | +$3,374,253,000 | $10.08 | 40 |